Microwave Imaging for Breast Tissue Study

AG
Overseen ByAnita Garland
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines the connection between the electrical properties of breast tissue and its density, as seen on mammograms. A special microwave imaging system (WVI-MIS-01-2022) facilitates this examination. The study targets healthy women who have had a mammogram in the last two years. It may be suitable for those not undergoing cancer treatment, without breast implants, and without implanted electronic devices. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research in breast imaging technology.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are undergoing chemotherapy or radiation treatment, you cannot participate in the study.

What prior data suggests that this microwave imaging system is safe for breast tissue?

Research has shown that microwave imaging systems, such as the WVI-MIS-01-2022, can detect differences in breast tissue. This study aims to understand the electrical properties of breast tissue in healthy women. These imaging systems are generally considered safe because they use low-power microwaves.

The reviewed sources provide no direct evidence of harm from this type of imaging, suggesting it is well-tolerated. The trial is in the "Not Applicable" phase, indicating a focus on gathering observational data rather than testing a new drug or invasive procedure. This typically suggests a lower risk to participants, as the emphasis is on imaging and observation rather than intervention.

In summary, while specific safety data for the WVI-MIS-01-2022 is not detailed, the low-power nature of microwave imaging and its use in observational studies suggest it is generally safe for human use.12345

Why are researchers excited about this trial?

Researchers are excited about the Microwave Imaging for Breast Tissue technique because it offers a non-invasive and radiation-free way to assess breast tissue. Unlike traditional methods like mammography, which use X-rays, this technique uses microwaves, which could be safer, especially for repeated use. This method might provide clearer images of breast tissue, helping in early detection and better differentiation of healthy and abnormal tissues, potentially leading to more accurate diagnoses.

What evidence suggests that this microwave imaging system is effective for assessing breast tissue?

This trial will evaluate the investigational treatment WVI-MIS-01-2022, which uses microwave imaging. Studies have shown that microwave imaging can differentiate between non-cancerous and cancerous breast lumps with about 79% accuracy. This method uses safe waves that do not harm the body. Research suggests that microwave imaging might outperform traditional X-ray mammograms, particularly for young women or those with dense breast tissue. It can detect changes in breast tissue that other methods might miss. Microwave imaging shows promise for early detection and monitoring of breast cancer.678910

Are You a Good Fit for This Trial?

This study is for healthy women aged 18 to 74 who have had a mammogram in the last two years. It aims to understand if there's a link between breast tissue properties measured by microwaves and breast density seen on mammograms.

Inclusion Criteria

I had a mammogram within the last 2 years.

Exclusion Criteria

Participants who are pregnant or breastfeeding
I currently have an infection in my breast.
Participants with breast implants
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Imaging Session

Participants undergo a single scanning session using a low-powered microwave imaging system to measure electrical properties of breast tissues

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • WVI-MIS-01-2022
Trial Overview The trial is testing a microwave imaging system, WVI-MIS-01-2022, to see if it can detect differences in electrical properties of breast tissues that correlate with what's seen on mammograms.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: WVI-MIS-01-2022Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+

Wave View Imaging

Collaborator

Trials
1
Recruited
50+

Alberta Innovates Health Solutions

Collaborator

Trials
54
Recruited
94,100+

Citations

Microwave imaging for breast cancer screeningMicrowave imaging presents several potential advantages including its non-ionising and harmless nature. This open, multicentric ...
Results from Clinical Investigation of the SAFE Microwave ...DISCUSSION. This study evaluated the efficacy of SAFE microwave breast imaging device in distinguishing benign and malignant breast lesions with an overall 79% ...
Feasibility of tumor detection with a transmission‐based ...Microwave imaging has been proposed for breast cancer detection, relying on differences between the microwave frequency properties of healthy ...
Microwave imaging for monitoring breast cancer treatment: A ...This study aims to detect treatment-related changes in breast tissue with a low-resolution microwave scanner.
Microwave Breast Imaging System Modules, Enhancing ...MWBI holds potential to outperform X-ray mammography's low sensitivity in young and dense breasts, thus supporting timelier detection of interval cancers, as a ...
Microwave Imaging for Breast Tissue StudyTrial Overview The trial is testing a microwave imaging system, WVI-MIS-01-2022, to see if it can detect differences in electrical properties of breast tissues ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36549991/
Results from Clinical Investigation of the SAFE Microwave ...The proposed classification model achieved the sensitivity, specificity, and accuracy of 79%, 77%, and 78%, respectively.
Results from Clinical Investigation of the SAFE Microwave ...The capability of the upgraded MBI device, SAFE, to provide breast tissue pathology at a high rate is evaluated, indicating that SAFE can be used to provide ...
Microwave Breast Lesion Classification – Results from ...... SAFE showed 79% sensitivity and 77% specificity, with 78% overall accuracy, detecting cancers as small as 4 mm. It performed better in non- ...
Microwave Breast Lesion Classification – Results from Clinical ...Article on Microwave Breast Lesion Classification – Results from Clinical Investigation of the SAFE Microwave Breast Cancer System, published in Academic ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security